Una nueva vacuna Tdap del Serum Institute de la India con perfil de seguridad e inmunogenicidad similar a las ya existentes
Aydin I, My M, Pisano F et al. Safety and immunogenicity of SIIPL Tdap, a new tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, in healthy subjects 4–65 years of age: A Phase II/III randomized, observer-blinded, active controlled, multicenter clinical study in Germany. Vaccine Available online 10 October 2023 https://www.x-mol.net/paper/article/1712330550595571712 Debido al incremento de…
Detalles
